These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 19419745)
1. Cholesterol biosynthesis modulation regulates dengue viral replication. Rothwell C; Lebreton A; Young Ng C; Lim JY; Liu W; Vasudevan S; Labow M; Gu F; Gaither LA Virology; 2009 Jun; 389(1-2):8-19. PubMed ID: 19419745 [TBL] [Abstract][Full Text] [Related]
2. Construction and characterization of a stable subgenomic dengue virus type 2 replicon system for antiviral compound and siRNA testing. Ng CY; Gu F; Phong WY; Chen YL; Lim SP; Davidson A; Vasudevan SG Antiviral Res; 2007 Dec; 76(3):222-31. PubMed ID: 17662475 [TBL] [Abstract][Full Text] [Related]
3. Construction of self-replicating subgenomic dengue virus 4 (DENV4) replicon. Alcaraz-Estrada SL; Del Angel R; Padmanabhan R Methods Mol Biol; 2014; 1138():131-50. PubMed ID: 24696335 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of squalene synthase but not squalene cyclase prevents mevalonate-mediated suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase synthesis at a posttranscriptional level. Peffley DM; Gayen AK Arch Biochem Biophys; 1997 Jan; 337(2):251-60. PubMed ID: 9016820 [TBL] [Abstract][Full Text] [Related]
5. Characterization of an efficient dengue virus replicon for development of assays of discovery of small molecules against dengue virus. Yang CC; Tsai MH; Hu HS; Pu SY; Wu RH; Wu SH; Lin HM; Song JS; Chao YS; Yueh A Antiviral Res; 2013 May; 98(2):228-41. PubMed ID: 23499649 [TBL] [Abstract][Full Text] [Related]
7. Understanding the molecular mechanism of host-based statin resistance in hepatitis C virus replicon containing cells. Delang L; Scheers E; Grabner M; Verpaalen B; Helsen N; Vanstreels E; Daelemans D; Verfaillie C; Neyts J Biochem Pharmacol; 2015 Aug; 96(3):190-201. PubMed ID: 26070251 [TBL] [Abstract][Full Text] [Related]
8. Fluvastatin reduces renal fibroblast proliferation and production of type III collagen: therapeutic implications for tubulointerstitial fibrosis. Ikeuchi H; Kuroiwa T; Yamashita S; Hiramatsu N; Maeshima A; Kaneko Y; Hiromura K; Ueki K; Nojima Y Nephron Exp Nephrol; 2004; 97(4):e115-22. PubMed ID: 15331935 [TBL] [Abstract][Full Text] [Related]
9. The anti‑dengue virus properties of statins may be associated with alterations in the cellular antiviral profile expression. Bryan-Marrugo OL; Arellanos-Soto D; Rojas-Martinez A; Barrera-Saldaña H; Ramos-Jimenez J; Vidaltamayo R; Rivas-Estilla AM Mol Med Rep; 2016 Sep; 14(3):2155-63. PubMed ID: 27431377 [TBL] [Abstract][Full Text] [Related]
10. Apoptosis of rheumatoid synovial cells by statins through the blocking of protein geranylgeranylation: a potential therapeutic approach to rheumatoid arthritis. Nagashima T; Okazaki H; Yudoh K; Matsuno H; Minota S Arthritis Rheum; 2006 Feb; 54(2):579-86. PubMed ID: 16447234 [TBL] [Abstract][Full Text] [Related]
11. Statin inhibition of Fc receptor-mediated phagocytosis by macrophages is modulated by cell activation and cholesterol. Loike JD; Shabtai DY; Neuhut R; Malitzky S; Lu E; Husemann J; Goldberg IJ; Silverstein SC Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2051-6. PubMed ID: 15345508 [TBL] [Abstract][Full Text] [Related]
13. Fluvastatin and lovastatin but not pravastatin induce neuroglial differentiation in human mesenchymal stem cells. Lee OK; Ko YC; Kuo TK; Chou SH; Li HJ; Chen WM; Chen TH; Su Y J Cell Biochem; 2004 Nov; 93(5):917-28. PubMed ID: 15389871 [TBL] [Abstract][Full Text] [Related]
14. Geranylgeranylpyrophosphate, a metabolite of mevalonate, regulates the cell cycle progression and DNA synthesis in human lymphocytes. Tatsuno I; Tanaka T; Oeda T; Yasuda T; Kitagawa M; Saito Y; Hirai A Biochem Biophys Res Commun; 1997 Dec; 241(2):376-82. PubMed ID: 9425279 [TBL] [Abstract][Full Text] [Related]
15. Effect of squalestatin 1 on the biosynthesis of the mevalonate pathway lipids. Thelin A; Peterson E; Hutson JL; McCarthy AD; Ericsson J; Dallner G Biochim Biophys Acta; 1994 Dec; 1215(3):245-9. PubMed ID: 7811707 [TBL] [Abstract][Full Text] [Related]
16. Identification of a small-molecule inhibitor of dengue virus using a replicon system. Hsu YC; Chen NC; Chen PC; Wang CC; Cheng WC; Wu HN Arch Virol; 2012 Apr; 157(4):681-8. PubMed ID: 22249364 [TBL] [Abstract][Full Text] [Related]
17. Differential inhibition of host cell cholesterol de novo biosynthesis and processing abrogates Eimeria bovis intracellular development. Hamid PH; Hirzmann J; Hermosilla C; Taubert A Parasitol Res; 2014 Nov; 113(11):4165-76. PubMed ID: 25199551 [TBL] [Abstract][Full Text] [Related]
18. Simvastatin inhibits C-reactive protein-induced pro-inflammatory changes in endothelial cells by decreasing mevalonate pathway products. Liang YJ; Shyu KG; Wang BW; Lai LP Cardiology; 2008; 110(3):182-90. PubMed ID: 18057884 [TBL] [Abstract][Full Text] [Related]
19. Utilizing liver-specific microRNA-122 to modulate replication of dengue virus replicon. Lee TC; Lin YL; Liao JT; Su CM; Lin CC; Lin WP; Liao CL Biochem Biophys Res Commun; 2010 Jun; 396(3):596-601. PubMed ID: 20412785 [TBL] [Abstract][Full Text] [Related]
20. Construction and characterization of a stable subgenomic replicon system of a Brazilian dengue virus type 3 strain (BR DEN3 290-02). Mosimann AL; de Borba L; Bordignon J; Mason PW; dos Santos CN J Virol Methods; 2010 Jan; 163(1):147-52. PubMed ID: 19761796 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]